世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000037312

チロシンキナーゼ阻害薬の世界市場(2024-2028)

TechNavio

Global Tyrosine Kinase Inhibitors Market 2024-2028

発刊日 2024/01/12

言語英語

体裁PDF/164ページ

ライセンス/価格164ページ

0000037312

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

チロシンキナーゼ阻害薬市場は2023年から2028年にかけて242億2,000万米ドル、予測期間中のCAGRは8.42%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、チロシンキナーゼ阻害薬の高い標的親和性と特異性、患者支援プログラムの利用可能性の上昇、世界のがんの有病率の増加が牽引しています。

調査範囲

  • 市場セグメント
    ➣ 流通チャネル別
      ◇ オフライン
      ◇ オンライン
    ➣ 製品別
      ◇ RTKI
      ◇ nRTKI
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域(ROW)

本調査では、今後数年間のチロシンキナーゼ阻害薬市場の成長を促進する主な要因の一つとして、市場ベンダー間の戦略的提携を挙げています。また、チロシンキナーゼ阻害薬治療における研究領域の拡大やバイオシミラーの上市増加は、市場の大きな需要につながっています。

チロシンキナーゼ阻害薬市場に関するレポートは、次の分野をカバーしています。

  • チロシンキナーゼ阻害薬市場の規模
  • チロシンキナーゼ阻害薬市場の予測
  • チロシンキナーゼ阻害薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ AbbVie Inc.
    ➣ Amgen Inc.
    ➣ AstraZeneca Plc
    ➣ Bayer AG
    ➣ Boehringer Ingelheim International GmbH
    ➣ Bristol Myers Squibb Co.
    ➣ Danaher Corp.
    ➣ Deciphera Pharmaceuticals Inc.
    ➣ エーザイ(Eisai Co. Ltd.)
    ➣ Eli Lilly and Co.
    ➣ Exelixis Inc.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Johnson and Johnson
    ➣ Merck KGaA
    ➣ Novartis AG
    ➣ Pfizer Inc.
    ➣ Puma Biotechnology Inc.
    ➣ Rigel Pharmaceuticals Inc.
    ➣ 武田製薬工業(Takeda Pharmaceutical Co. Ltd.)
    ➣ 東京化成工業(Tokyo Chemical Industry Co. Ltd.)

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global tyrosine kinase inhibitors market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global tyrosine kinase inhibitors market 2018 - 2022 ($ billion)
4.2 Distribution channel Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Distribution channel Segment 2018 - 2022 ($ billion)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Offline - Market size and forecast 2023-2028
Exhibit 34: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Offline - Year-over-year growth 2023-2028 (%)
6.4 Online - Market size and forecast 2023-2028
Exhibit 38: Chart on Online - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Online - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Distribution Channel
Exhibit 42: Market opportunity by Distribution Channel ($ billion)
Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Product
7.1 Market segments
Exhibit 44: Chart on Product - Market share 2023-2028 (%)
Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 46: Chart on Comparison by Product
Exhibit 47: Data Table on Comparison by Product
7.3 RTKIs - Market size and forecast 2023-2028
Exhibit 48: Chart on RTKIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 49: Data Table on RTKIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Chart on RTKIs - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on RTKIs - Year-over-year growth 2023-2028 (%)
7.4 nRTKIs - Market size and forecast 2023-2028
Exhibit 52: Chart on nRTKIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on nRTKIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on nRTKIs - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on nRTKIs - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
Exhibit 56: Market opportunity by Product ($ billion)
Exhibit 57: Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 107: AbbVie Inc. - Overview
Exhibit 108: AbbVie Inc. - Product / Service
Exhibit 109: AbbVie Inc. - Key news
Exhibit 110: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 111: Amgen Inc. - Overview
Exhibit 112: Amgen Inc. - Product / Service
Exhibit 113: Amgen Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 114: AstraZeneca Plc - Overview
Exhibit 115: AstraZeneca Plc - Product / Service
Exhibit 116: AstraZeneca Plc - Key news
Exhibit 117: AstraZeneca Plc - Key offerings
12.6 Bayer AG
Exhibit 118: Bayer AG - Overview
Exhibit 119: Bayer AG - Business segments
Exhibit 120: Bayer AG - Key news
Exhibit 121: Bayer AG - Key offerings
Exhibit 122: Bayer AG - Segment focus
12.7 Boehringer Ingelheim International GmbH
Exhibit 123: Boehringer Ingelheim International GmbH - Overview
Exhibit 124: Boehringer Ingelheim International GmbH - Business segments
Exhibit 125: Boehringer Ingelheim International GmbH - Key news
Exhibit 126: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 127: Boehringer Ingelheim International GmbH - Segment focus
12.8 Bristol Myers Squibb Co.
Exhibit 128: Bristol Myers Squibb Co. - Overview
Exhibit 129: Bristol Myers Squibb Co. - Product / Service
Exhibit 130: Bristol Myers Squibb Co. - Key news
Exhibit 131: Bristol Myers Squibb Co. - Key offerings
12.9 Danaher Corp.
Exhibit 132: Danaher Corp. - Overview
Exhibit 133: Danaher Corp. - Business segments
Exhibit 134: Danaher Corp. - Key news
Exhibit 135: Danaher Corp. - Key offerings
Exhibit 136: Danaher Corp. - Segment focus
12.10 Eisai Co. Ltd.
Exhibit 137: Eisai Co. Ltd. - Overview
Exhibit 138: Eisai Co. Ltd. - Business segments
Exhibit 139: Eisai Co. Ltd. - Key offerings
Exhibit 140: Eisai Co. Ltd. - Segment focus
12.11 Eli Lilly and Co.
Exhibit 141: Eli Lilly and Co. - Overview
Exhibit 142: Eli Lilly and Co. - Product / Service
Exhibit 143: Eli Lilly and Co. - Key news
Exhibit 144: Eli Lilly and Co. - Key offerings
12.12 Exelixis Inc.
Exhibit 145: Exelixis Inc. - Overview
Exhibit 146: Exelixis Inc. - Product / Service
Exhibit 147: Exelixis Inc. - Key offerings
12.13 F. Hoffmann La Roche Ltd.
Exhibit 148: F. Hoffmann La Roche Ltd. - Overview
Exhibit 149: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 150: F. Hoffmann La Roche Ltd. - Key news
Exhibit 151: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 152: F. Hoffmann La Roche Ltd. - Segment focus
12.14 Johnson and Johnson
Exhibit 153: Johnson and Johnson - Overview
Exhibit 154: Johnson and Johnson - Business segments
Exhibit 155: Johnson and Johnson - Key news
Exhibit 156: Johnson and Johnson - Key offerings
Exhibit 157: Johnson and Johnson - Segment focus
12.15 Novartis AG
Exhibit 158: Novartis AG - Overview
Exhibit 159: Novartis AG - Business segments
Exhibit 160: Novartis AG - Key offerings
Exhibit 161: Novartis AG - Segment focus
12.16 Pfizer Inc.
Exhibit 162: Pfizer Inc. - Overview
Exhibit 163: Pfizer Inc. - Product / Service
Exhibit 164: Pfizer Inc. - Key news
Exhibit 165: Pfizer Inc. - Key offerings
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 167: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 168: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 169: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 170: Inclusions checklist
Exhibit 171: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 172: Currency conversion rates for US$
13.4 Research methodology
Exhibit 173: Research methodology
Exhibit 174: Validation techniques employed for market sizing
Exhibit 175: Information sources
13.5 List of abbreviations
Exhibit 176: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global tyrosine kinase inhibitors market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Distribution channel Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Online - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Distribution Channel ($ billion)
Exhibits43: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits44: Chart on Product - Market share 2023-2028 (%)
Exhibits45: Data Table on Product - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Product
Exhibits47: Data Table on Comparison by Product
Exhibits48: Chart on RTKIs - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on RTKIs - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on RTKIs - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on RTKIs - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on nRTKIs - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on nRTKIs - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on nRTKIs - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on nRTKIs - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Product ($ billion)
Exhibits57: Data Table on Market opportunity by Product ($ billion)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ billion)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: AbbVie Inc. - Overview
Exhibits108: AbbVie Inc. - Product / Service
Exhibits109: AbbVie Inc. - Key news
Exhibits110: AbbVie Inc. - Key offerings
Exhibits111: Amgen Inc. - Overview
Exhibits112: Amgen Inc. - Product / Service
Exhibits113: Amgen Inc. - Key offerings
Exhibits114: AstraZeneca Plc - Overview
Exhibits115: AstraZeneca Plc - Product / Service
Exhibits116: AstraZeneca Plc - Key news
Exhibits117: AstraZeneca Plc - Key offerings
Exhibits118: Bayer AG - Overview
Exhibits119: Bayer AG - Business segments
Exhibits120: Bayer AG - Key news
Exhibits121: Bayer AG - Key offerings
Exhibits122: Bayer AG - Segment focus
Exhibits123: Boehringer Ingelheim International GmbH - Overview
Exhibits124: Boehringer Ingelheim International GmbH - Business segments
Exhibits125: Boehringer Ingelheim International GmbH - Key news
Exhibits126: Boehringer Ingelheim International GmbH - Key offerings
Exhibits127: Boehringer Ingelheim International GmbH - Segment focus
Exhibits128: Bristol Myers Squibb Co. - Overview
Exhibits129: Bristol Myers Squibb Co. - Product / Service
Exhibits130: Bristol Myers Squibb Co. - Key news
Exhibits131: Bristol Myers Squibb Co. - Key offerings
Exhibits132: Danaher Corp. - Overview
Exhibits133: Danaher Corp. - Business segments
Exhibits134: Danaher Corp. - Key news
Exhibits135: Danaher Corp. - Key offerings
Exhibits136: Danaher Corp. - Segment focus
Exhibits137: Eisai Co. Ltd. - Overview
Exhibits138: Eisai Co. Ltd. - Business segments
Exhibits139: Eisai Co. Ltd. - Key offerings
Exhibits140: Eisai Co. Ltd. - Segment focus
Exhibits141: Eli Lilly and Co. - Overview
Exhibits142: Eli Lilly and Co. - Product / Service
Exhibits143: Eli Lilly and Co. - Key news
Exhibits144: Eli Lilly and Co. - Key offerings
Exhibits145: Exelixis Inc. - Overview
Exhibits146: Exelixis Inc. - Product / Service
Exhibits147: Exelixis Inc. - Key offerings
Exhibits148: F. Hoffmann La Roche Ltd. - Overview
Exhibits149: F. Hoffmann La Roche Ltd. - Business segments
Exhibits150: F. Hoffmann La Roche Ltd. - Key news
Exhibits151: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits152: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits153: Johnson and Johnson - Overview
Exhibits154: Johnson and Johnson - Business segments
Exhibits155: Johnson and Johnson - Key news
Exhibits156: Johnson and Johnson - Key offerings
Exhibits157: Johnson and Johnson - Segment focus
Exhibits158: Novartis AG - Overview
Exhibits159: Novartis AG - Business segments
Exhibits160: Novartis AG - Key offerings
Exhibits161: Novartis AG - Segment focus
Exhibits162: Pfizer Inc. - Overview
Exhibits163: Pfizer Inc. - Product / Service
Exhibits164: Pfizer Inc. - Key news
Exhibits165: Pfizer Inc. - Key offerings
Exhibits166: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits167: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits168: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits169: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits170: Inclusions checklist
Exhibits171: Exclusions checklist
Exhibits172: Currency conversion rates for US$
Exhibits173: Research methodology
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Information sources
Exhibits176: List of abbreviations

この商品のレポートナンバー

0000037312

TOP